Recall StatusTerminated
Date Initiated2022-05-18
Date Terminated2025-02-13
Product Quantity113 units; Extended: 52 units
Reason for Recall
Positive bias with Lithium Heparin plasma samples from
individuals that are expected to be below the 99th percentile of 0.07 ng/mL [0.07 g/L], may lead to inappropriate intervention for myocardial infarction
Firm Action
****Recall Expanded 9-21-22***
US Customers were sent Urgent Medical Device Correction (DC-22-2.B.US) on 09/21/2022 and an Urgent Field Safety Notice UFSN DC-22-02.B.OUS) was issued to all OUS Siemens reporting sites with affected customers, for distribution and regional reporting to their local competent authorities beginning on 09/26/2022.
Letter informs them to use serum patient samples only when utilizing lot BA3088. Laboratories unable to use serum patient samples for testing are to request a no charge replacement for their impacted reagent.
Siemens issued Urgent Medical Device Correction (UMDC) to US affected customers by FedEx beginning on 05/18/2022. An Urgent Field Safety Notice (UFSN) was issued to all OUS Siemens reporting sites for distribution and regional reporting to their local competent authorities beginning on 05/18/2022. Letter states reason for recall, health risk and action to take:
Please review this letter with your Medical Director.
Siemens recommends using serum patient samples only when using the lots listed in
Table 1. If your laboratory is not able to use serum samples, please discard the reagent and
complete the attached Product Replacement form for a no-charge replacement product.
Review your inventory to determine possible replacement needs and to provide information
to Siemens for reporting to the Authorities.
Complete and return the Field Correction Effectiveness Check/Product Replacement Form
attached to this letter within 30 days to Siemens Healthineers for reporting to the
Authorities.
If you have received any complaints of illness or adverse events associated with the
products listed in Table 1, immediately contact your local Siemens Healthineers Customer Care Center or your local Siemens Healthineers Technical Support Representative.
Root Cause
Under Investigation by firm
Distribution Pattern
Worldwide distribution - US Nationwide distribution in the states of AL, AR, CA, IL MN, MS, NC, ND, NH, OK, SD, TN, TX, WA and the countries of Argentina, Brazil, Canada, France, Germany, India, Mexico, Poland, Portugal, Slovakia, Spain.
Official Source
View FDA Recall →Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.